Aragen Life Sciences Limited, Bachem Holding AG (BANB) and Bespak Limited: reported emissions and climate targets side by side
Each figure is the company’s latest reported year, linked to its filing. Figures as of November 2026.
Scope 1 and 2 are the greenhouse gases from a company’s own operations and the energy it buys; Scope 3 is everything else in its value chain. All figures are in tonnes of CO₂ equivalent (tCO₂e). Industry is the company’s sector on the SBTi registry, the Science Based Targets initiative that checks corporate climate targets.
Scope 1 and 2 emissions
- Aragen Life Sciences Limited reports more Scope 1 and 2 emissions than 21 of the other 70 pharmaceuticals and biotechnology companies with a figure for 2023 or later.
- Bachem Holding AG (BANB) reports more Scope 1 and 2 emissions than 7 of the other 70 pharmaceuticals and biotechnology companies with a figure for 2023 or later.
- Bespak Limited reports more Scope 1 and 2 emissions than 25 of the other 70 pharmaceuticals and biotechnology companies with a figure for 2023 or later.
The latest figures come from different years (2024 and 2025), so the gap partly reflects timing.
These are absolute footprints, so they measure a company’s size as much as its efficiency. A large company can be efficient and still sit near the top.
tCO₂e, latest reported year for each company
- Aragen Life Sciences Limited40,516 tCO₂e, 2024
- Bachem Holding AG (BANB)5,564 tCO₂e, 2025
- Bespak Limited48,390 tCO₂e, 2025
- Pharmaceuticals and biotechnology median94,489 tCO₂e
Scope 3 emissions
- Scope 3 is 50% of Aragen Life Sciences Limited’s total reported footprint.
- Scope 3 is 96% of Bachem Holding AG (BANB)’s total reported footprint.
- Scope 3 is 91% of Bespak Limited’s total reported footprint.
tCO₂e, latest reported year for each company
- Aragen Life Sciences Limited40,817 tCO₂e, 2024
- Bachem Holding AG (BANB)138,944 tCO₂e, 2025
- Bespak Limited516,039 tCO₂e, 2025
Change over time
The SBTi cross-sector pathway for 1.5°C asks for about 4.2% less each year. A change needs two reported years at most three years apart, the latest from 2023 or later.
Average change a year, compound, between the two latest reported years
- Aragen Life Sciences Limiteddown 14.1% a year2023 to 2024
- Bachem Holding AG (BANB)down 27.2% a year2024 to 2025
- Bespak LimitedNot enough years reported
- SBTi 1.5°C referencedown 4.2% a year
Climate targets
Aragen Life Sciences Limited
- Near-term target
- Validated, aligned with 1.5°C
- Target year
- 2033
- Net-zero target
- 2050
Bachem Holding AG (BANB)
- Near-term target
- Validated, aligned with 1.5°C
- Target year
- 2030
- Net-zero target
- None
Bespak Limited
- Near-term target
- Validated, aligned with 1.5°C
- Target year
- 2033
- Net-zero target
- 2050
Carbon credit retirements
Tonnes of CO₂e retired, where the company is the named beneficiary
- Aragen Life Sciences LimitedNone found
- Bachem Holding AG (BANB)None found
- Bespak LimitedNone found
Retirements come from public registries (CarbonPlan and VROD) and cover November 2024 onward, matched to companies by name, so a missing figure does not mean a company never retired credits.
Sources
Aragen Life Sciences Limited
Bachem Holding AG (BANB)
Bespak Limited
How the comparison works
- Each company’s figures are its latest reported year in the emissions registry, from its own filings. A gap means the company has not reported that figure; it is never filled in or estimated.
- A zero or implausibly large figure (Scope 1 and 2 above 100 million tCO₂e, or Scope 3 above 1 billion) is shown with a “figure under review” tag and never ranked.
- The industry position compares a company’s latest Scope 1 and 2 figure from 2023 or later with every other company in the same SBTi industry that has one. It is shown only when at least 10 companies report.
- Profiles Carbon3 prepared ahead of a claim are shown here but left out of industry statistics.
Need a deeper peer review for your company?
Contact us